To determine whether SFN could promote CAR-T cell cytotoxicity in patients with cancer who received adoptive immunotherapy, we simultaneously treated patients with SFN orally and examined PD-1 expression and cytokine secretion of CD8+ CAR-T cells in the blood drawn at different time points (Fig. 6A). This evidence concerns the gene CD8A and cancer.